Modifying Cancer-Related Fatigue by Optimizing Sleep Quality

Authors:
Ann Malone Berger From the University of Nebraska Medical Center, Omaha, Nebraska; National Institutes of Health, Bethesda, Maryland, and PhD candidate at the University of Utah, College of Nursing, Salt Lake City, Utah.

Search for other papers by Ann Malone Berger in
Current site
Google Scholar
PubMed Close
 PhD, RN, AOCN
and
Sandra A. Mitchell From the University of Nebraska Medical Center, Omaha, Nebraska; National Institutes of Health, Bethesda, Maryland, and PhD candidate at the University of Utah, College of Nursing, Salt Lake City, Utah.

Search for other papers by Sandra A. Mitchell in
Current site
Google Scholar
PubMed Close
 CRNP, MScN, AOCN
Volume/Issue:
Volume 6: Issue 1
Online Publication Date:
Jan 2008
DOI:
https://doi.org/10.6004/jnccn.2008.0002
Full access

Cancer-related fatigue is reported by patients to be the most distressing and persistent symptom experienced during and after treatment. Unrelieved fatigue often accompanies other symptoms and leads to decreased physical functioning and lower health-related quality of life. Various factors, including daytime sleepiness and sleep disturbances, have been reported to influence perceptions of fatigue. This article shares current knowledge about the relationships among cancer-related fatigue, sleep disturbances, and daytime sleepiness, and makes recommendations for routine screening, assessment, and interventions to modify fatigue through optimizing sleep quality in adult cancer patients. Evidence is reviewed for nonpharmacologic and pharmacologic interventions for optimizing sleep quality in patients with acute or chronic insomnia secondary to medical illnesses, including cancer. A summary of interventions is presented that focuses on optimizing sleep quality in attempt to lower fatigue. These interventions may be helpful for adult cancer patients experiencing insomnia but will require further testing to establish their efficacy in this population. Recommendations for research are provided, including the need to increase knowledge on the relationships among fatigue, sleep disturbances, daytime sleepiness, and other symptoms in various disease sites, stages, and treatments of cancer and the need for further testing of the measurements used for the evaluation of sleep quality in clinical practice and research.

Correspondence: Ann M. Berger, PhD, RN, AOCN, 985330 Nebraska Medical Center, Omaha, NE 68198-5330. E-mail: aberger@unmc.edu
  • Collapse
  • Expand
  • 1.

    Prue G, Rankin J, Allen J et al.. Cancer-related fatigue: a critical appraisal. Eur J Cancer 2006;42:846–863.

  • 2.

    Mock V, Abernethy AP, Atkinson A et al.. NCCN Clinical Practice Guidelines in Oncology — Cancer-Related Fatigue, v.2.2007. Available at: http://www.nccn.org/. Accessed September 26, 2007.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Piper B. Fatigue. In: Carrieri-Kohlman V, Lindsey A, West C, eds. Pathophysiological Phenomena in Nursing, 3rd ed. St Louis, MO: Saunders; 2003:209–234.

  • 4.

    Hofman M, Ryan JL, Figueroa-Moseley CD et al.. Cancer-related fatigue: the scale of the problem. Oncologist 2007;12(Suppl 1):4–10.

  • 5.

    Barsevick AM, Whitmer K, Nail LM et al.. Symptom cluster research: conceptual, design, measurement, and analysis issues. J Pain Symptom Manage 2006;31:85–95.

  • 6.

    Davidson JR, MacLean AW, Brundage MD et al.. Sleep disturbance in cancer patients. Soc Sci Med 2002;54:1309–1321.

  • 7.

    Savard J, Morin CM. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol 2001;19:895–908.

  • 8.

    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Text Revision: DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9.

    Devine EB, Hakim Z, Green J. A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adults. Pharmacoeconomics 2005;23:889–912.

  • 10.

    Lee KA, Ward TM. Critical components of a sleep assessment for clinical practice settings. Issues Ment Health Nurs 2005;26:739–750.

  • 11.

    Savard MH, Savard J, Simard S et al.. Empirical validation of the Insomnia Severity Index in cancer patients. Psychooncology 2005;14:429–441.

  • 12.

    Berger A, Parker K, Young-McCaughan S et al.. Sleep wake disturbances in people with cancer and their caregivers: state of the science. Oncol Nurs Forum 2005;32:E98–E126.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13.

    National Cancer Institute. Sleep Disorders (PDQ®) 02/16/2006. Available at: http://www.cancer.gov/cancertopics/pdq/supportivecare/sleepdisorders/healthprofessional/. Accessed September 26, 2007.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14.

    Buysse DJ, Ancoli-Israel S, Edinger JD et al.. Recommendations for a standard research assessment of insomnia. Sleep 2006;29:1155–1173.

  • 15.

    Lee KA. Impaired sleep. In: Carrieri-Kohlman V, Lindsey A, West C, eds. Pathophysiological Phenomena in Nursing, 3rd ed. St. Louis, MO: Saunders; 2003:363–385.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16.

    Spielman AJ, Glovinsky P. A conceptual framework of insomnia for primary care practitioners: predisposing, precipitating and perpetuating factors. Sleep Medicine Alerts 2004;9:1–6.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17.

    Borbely AA, Achermann P. Sleep homeostasis and models of sleep regulation. J Biol Rhythms 1999;14:557–568.

  • 18.

    Vena C, Parker K, Cunningham M et al.. Sleep-wake disturbances in people with cancer part I: an overview of sleep, sleep regulation, and effects of disease and treatment. Oncol Nurs Forum 2004;31:735–746.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19.

    Payne JK. A neuroendocrine-based regulatory fatigue model. Biol Res Nurs 2004;6:141–150.

  • 20.

    Bower JE, Ganz PA, Dickerson SS et al.. Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology 2005;30:92–100.

  • 21.

    Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 2007;21:153–160.

  • 22.

    Lee BN, Dantzer R, Langley KE et al.. A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation 2004;11:279–292.

  • 23.

    Payne JK. A neuroendocrine-based regulatory fatigue model. Biol Res Nurs 2004;6:141–150.

  • 24.

    Bower JE. Cancer-related fatigue: links with inflammation in cancer patients and survivors. Brain Behav Immun 2007;21:863–871.

  • 25.

    Ryan JL, Carroll JK, Ryan EP et al.. Mechanisms of cancer-related fatigue. Oncologist 2007;12(Suppl 1):22–34.

  • 26.

    Wood LJ, Nail LM, Gilster A et al.. Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines. Oncol Nurs Forum 2006;33:535–542.

  • 27.

    Berger AM, Sankaranarayanan J, Watanabe-Galloway S. Current methodological approaches to the study of sleep disturbances and quality of life in adults with cancer: a systematic review. Psychooncology 2007;16:401–420.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 28.

    American Academy of Sleep Medicine. International Classification of Sleep Disorders: Diagnostic & Coding Manual, 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29.

    Carpenter JS, Elam JL, Ridner SH et al.. Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum 2004;31:591–598.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30.

    NIH. National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. Sleep 2005;28:1049–1057.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 31.

    Alfano CM, Rowland JH. Recovery issues in cancer survivorship: a new challenge for supportive care. Cancer J 2006;12:432–443.

  • 32.

    Bardwell WA, Profant J, Casden DR et al.. The relative importance of specific risk factors for insomnia in women treated for early-stage breast cancer. Psychooncology 2007; epub ahead of print.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33.

    Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540–545.

  • 34.

    Ancoli-Israel S. Sleep and fatigue in cancer patients. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. Philadelphia: Saunders; 2005:1218–1224.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35.

    Roscoe JA, Kaufman ME, Matteson-Rusby SE et al.. Cancer-related fatigue and sleep disorders. Oncologist 2007:12(Suppl 1):35–42.

  • 36.

    Barton-Burke M. Cancer-related fatigue and sleep disturbances. Cancer Nurs 2006;29;2(Suppl 2):72–77.

  • 37.

    de Jong N, Courtens AM, Abu-Saad HH et al.. Fatigue in patients with breast cancer receiving adjuvant chemotherapy: a review of the literature. Cancer Nurs 2002;25:283–297; quiz 298–289.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38.

    Donovan KA, Jacobsen PB. Fatigue, depression, and insomnia: evidence for a symptom cluster in cancer. Semin Oncol Nurs 2007;23:127–135.

  • 39.

    Fiorentino L, Ancoli-Israel S. Insomnia and its treatment in women with breast cancer. Sleep Med Rev 2006;10:419–429.

  • 40.

    Lee K, Cho M, Miaskowski C et al.. Impaired sleep and rhythms in persons with cancer. Sleep Med Rev 2004;8:199–212.

  • 41.

    Theobald DE. Cancer pain, fatigue, distress, and insomnia in cancer patients. Clin Cornerstone 2004;6(Suppl 1D):S15–21.

  • 42.

    Ancoli-Israel S, Liu L, Marler MR et al.. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer 2006;14:201–209.

  • 43.

    Berger AM, Farr LA, Kuhn BR et al.. Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy. J Pain Symptom Manage 2007;33:398–409.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 44.

    Jacobsen PB, Hann DM, Azzarello LM et al.. Fatigue in women receiving adjuvant chemotherapy for breast cancer: characteristics, course, and correlates. J Pain Symptom Manage 1999;18:233–242.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 45.

    Berger AM, Farr L. The influence of daytime inactivity and night-time restlessness on cancer-related fatigue. Oncol Nurs Forum 1999;26:1663–1671.

  • 46.

    Kuo HH, Chiu MJ, Liao WC et al.. Quality of sleep and related factors during chemotherapy in patients with stage I/II breast cancer. J Formos Med Assoc 2006;105:64–69.

  • 47.

    Barton-Burke M. Cancer-related fatigue and sleep disturbances. Further research on the prevalence of these two symptoms in long-term cancer survivors can inform education, policy, and clinical practice. Am J Nurs 2006;106(Suppl 3):72–77.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 48.

    Bower JE, Ganz PA, Desmond KA et al.. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 2000;18:743–753.

  • 49.

    Broeckel JA, Jacobsen PB, Horton J et al.. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 1998;16:1689–1696.

  • 50.

    Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer 2002;38:27–43.

  • 51.

    Buysse DJ, Reynolds CF, Monk TH et al.. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193–213.

  • 52.

    Miaskowski C, Lee KA. Pain, fatigue, and sleep disturbances in oncology outpatients receiving radiation therapy for bone metastasis: a pilot study. J Pain Symptom Manage 1999;17:320–332.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 53.

    Mystakidou K, Parpa E, Tsilika E et al.. Sleep quality in advanced cancer patients. J Psychosom Res 2007;62:527–533.

  • 54.

    Berger AM. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum 1998;25:51–62.

  • 55.

    Berger AM, Higginbotham P. Correlates of fatigue during and following adjuvant breast cancer chemotherapy: a pilot study. Oncol Nurs Forum 2000;27:1443–1448.

  • 56.

    Roscoe JA, Morrow GR, Hickok JT et al.. Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer 2002;10:329–336.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 57.

    Levin RD, Daehler MA, Grutsch JF et al.. Circadian function in patients with advanced non-small-cell lung cancer. Br J Cancer 2005;93:1202–1208.

  • 58.

    Rich T, Innominato PF, Boerner J et al.. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clin Cancer Res 2005;11:1757–1764.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 59.

    Glaus A, Boehme CH, Thűrlimann B et al.. Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment. Ann Oncol 1006;17:801–806.

  • 60.

    Given B, Given C, Azzouz F et al.. Physical functioning of elderly cancer patients prior to diagnosis and following initial treatment. Nurs Res 2001;50:222–232.

  • 61.

    Fox SW, Lyon D, Farace E. Symptom clusters in patients with high-grade glioma. J Nurs Scholarsh 2007;39:61–67.

  • 62.

    Barsevick AM, Dudley WN, Beck SL. Cancer-related fatigue, depressive symptoms, and functional status: a mediation model. Nurs Res 2006;55:366–372.

  • 63.

    Morin CM, Bootzin RR, Buysse DJ et al.. Psychological and behavioral treatment of insomnia: update of the recent evidence (1998–2004). Sleep 2006;29:1398–1414.

  • 64.

    Morgenthaler T, Kramer M, Alessi C et al.. Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of Sleep Medicine report. Sleep 2006;29:1415–1419.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 65.

    Sackett DL. Rules of evidence and clinical recommendations for the management of patients. Can J Cardiol 1993;9:487–489.

  • 66.

    Barton S, ed. Clinical Evidence Concise: The International Source of the Best Available Evidence for Effective Health Care, 7th ed. Kingsport, TN: BMJ Publishing Group; 2002.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 67.

    Mitchell SA, Friese CR. Weight of evidence. Available at: http://www.ons.org/outcomes/tables/documents/woevidence.pdf. Accessed September 26, 2007.

  • 68.

    Gobel BH, Beck SL, O'Leary C. Nursing-sensitive patient outcomes: the development of the putting evidence into practice resources for nursing practice. Clin J Oncol Nurs 2006;10:621–624.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 69.

    Mitchell SA, Beck SL, Hood LE et al.. Putting evidence into practice: evidence-based interventions for fatigue during and following cancer and its treatment. Clin J Oncol Nurs 2007;11:99–113.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 70.

    Page MS, Berger AM, Johnson LB. Putting evidence into practice: evidence-based interventions for sleep-wake disturbances. Clin J Oncol Nurs 2006;10:753–767.

  • 71.

    Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 1994;151:1172–1180.

  • 72.

    Belanger L, Savard J, Morin CM. Clinical management of insomnia using cognitive therapy. Behav Sleep Med 2006;4:179–198.

  • 73.

    Szuba MP, Kloss JE, Dinges DF. Insomnia Principles and Management. New York: Cambridge University Press; 2003.

  • 74.

    Currie SR, Wilson KG, Pontefract AJ et al.. Cognitive-behavioral treatment of insomnia secondary to chronic pain. J Consult Clin Psycho 2000;68:407–416.

  • 75.

    Lichstein KL, Wilson NM, Johnson CT. Psychological treatment of secondary insomnia. Psychol Aging 2000;15:232–240.

  • 76.

    Currie SR, Clark S, Hodgins DC et al.. Randomized controlled trial of brief cognitive-behavioural interventions for insomnia in recovering alcoholics. Addiction 2004;99:1121–1132.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 77.

    Rybarczyk B, Lopez M, Benson R et al.. Efficacy of two behavioral treatment programs for comorbid geriatric insomnia. Psychol Aging 2002;17:288–298.

  • 78.

    Berger AM, VonEssen S, Kuhn BR et al.. Feasibility of a sleep intervention during adjuvant breast cancer chemotherapy. Oncol Nurs Forum 2002;29:1431–1441.

  • 79.

    Berger AM, Von Essen S, Kuhn BR et al.. Adherence, sleep, and fatigue outcomes after adjuvant breast cancer chemotherapy: results of a feasibility intervention study. Oncol Nurs Forum 2003;30:513–522.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 80.

    Davidson JR, Waisberg JL, Brundage MD et al.. Nonpharmacologic group treatment of insomnia: a preliminary study with cancer survivors. Psychooncology 2001;10:389–397.

  • 81.

    Quesnel C, Savard J, Simard S et al.. Efficacy of cognitive-behavioral therapy for insomnia in women treated for nonmetastatic breast cancer. J Consult Clin Psychol 2003;71:189–200.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 82.

    Savard J, Simard S, Ivers H et al.. Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: sleep and psychological effects. J Clin Oncol 2005;23:6083–6096.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 83.

    Carlson LE, Garland SN. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med 2005;12:278–285.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 84.

    Kim Y, Roscoe JA, Morrow GR. The effects of information and negative affect on severity of side effects from radiation therapy for prostate cancer. Support Care Cancer 2002;10:416–421.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 85.

    Mock V, Dow KH, Meares CJ et al.. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 1997;24:991–1000.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 86.

    Culpepper L. Secondary insomnia in the primary care setting: review of diagnosis, treatment, and management. Curr Med Res Opin 2006;22:1257–1268.

  • 87.

    Hirst A, Sloan R. Benzodiazepines and related drugs for insomnia in palliative care. Cochrane Database Syst Rev 2004;4:CD003346.

  • 88.

    Taibi DM, Landis CA, Petry H et al.. A systematic review of valerian as a sleep aid: safe but not effective. Sleep Med Rev 2007;11:209–230.

  • 89.

    Bain KT. Management of chronic insomnia in elderly persons. Am J Geriatr Pharmacother 2006;4:168–192.

  • 90.

    Dolder C, Nelson M, McKinsey J. Use of non-benzodiazepine hypnotics in the elderly: are all agents the same? CNS Drugs 2007;21:389–405.

  • 91.

    Dundar Y, Dodd S, Strobl J et al.. Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Hum Psychopharmacol 2004;19:305–322.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 92.

    Glass J, Lanctot KL, Herrmann N et al.. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005;331:1169–1173.

  • 93.

    Bruera E, Driver L, Barnes EA et al.. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol 2003;21:4439–4443.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 94.

    Bruera E, Strasser F, Shen L et al.. The effect of donepezil on sedation and other symptoms in patients receiving opioids for cancer pain: a pilot study. J Pain Symptom Manage 2003;26:1049–1054.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 95.

    Bruera E, Valero V, Driver L et al.. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 2006;24:2073–2078.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 96.

    Cullum JL, Wojciechowski AE, Pelletier G et al.. Bupropion sustained release treatment reduces fatigue in cancer patients. Can J Psychiatry 2004;49:139–144.

  • 97.

    Hanna A, Sledge G, Mayer ML et al.. A phase II study of methylphenidate for the treatment of fatigue. Support Care Cancer 2006;14:210–215.

  • 98.

    Moss EL, Simpson JS, Pelletier G et al.. An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners. Psychooncology 2006;15:259–267.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 99.

    Sarhill N, Walsh D, Nelson KA et al.. Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study. Am J Hosp Palliat Care 2001;18:187–192.

  • 100.

    Schwartz AL, Thompson JA, Masood N. Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate. Oncol Nurs Forum 2002;29:E85–E90.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 101.

    Shaw EG, Rosdhal R, D'Agostino RB Jr et al.. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol 2006;24:1415–1420.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 102.

    Sugawara Y, Akechi T, Shima Y et al.. Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study. Palliat Med 2002;16:261–263.

  • 103.

    Capuron L, Gumnick JF, Musselman DL et al.. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 2002;26:643–652.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 104.

    Morrow GR, Hickok JT, Roscoe JA et al.. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol 2003;21:4635–4641.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 105.

    Roscoe JA, Morrow GR, Hickok JT et al.. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 2005;89:243–249.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 106.

    Weitzner MA, Moncello J, Jacobsen PB et al.. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer. J Pain Symptom Manage 2002;23:337–345.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 107.

    Caraceni A, Simonetti F. Psychostimulants: new concepts for palliative care from the modafinil experience? J Pain Symptom Manage 2004;28:97–99.

  • 108.

    Cox JM, Pappagallo M. Modafinil: a gift to portmanteau. Am J Hosp Palliat Care 2001;18:408–410.

  • 109.

    Prommer E. Modafinil: is it ready for prime time? J Opioid Manag 2006;2:130–136.

  • 110.

    Rivera VM. Modafinil for the treatment of diminished responsiveness in a patient recovering from brain surgery. Brain Inj 2005;19:725–727.

  • 111.

    Spathis A, Morrish E, Booth S et al.. Selective circadian rhythm disturbance in cerebral lymphoma. Sleep Med 2003;4:583–586.

  • 112.

    Torta R, Berra C, Binaschi L et al.. Amisulpride in the short-term treatment of depressive and physical symptoms in cancer patients during chemotherapies. Support Care Cancer 2007;15:539–546.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 113.

    Food and Drug Administration. (March 14, 2007). FDA News, March 14, 2007. Available at: http://www.fda.gov/bbs/topics/NEWS/2007/NEW01587.html. Accessed September 26, 2007.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 114.

    Mayers AG, Baldwin DS. Antidepressants and their effect on sleep. Hum Psychopharmacol 2005;20:533–559.

Copyright:
Copyright © 2008 by the National Comprehensive Cancer Network
Page Numbers:
11
Article Category:
Research Article
Received:
31 May 2007
Accepted:
28 Jun 2007
Print Publication Date:
01 Jan 2008
Online Publication Date:
Jan 2008
Keywords:
Cancer; fatigue; sleep disturbances; daytime sleepiness; symptom management; evidence-based practice
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 867 206 32
PDF Downloads 681 174 18
EPUB Downloads 0 0 0